Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]

G. Tonini; C. Bizzarri; R. Bonfanti; M. Vanelli; F. Cerutti; E. Faleschini; F. Meschi; F. Prisco; E. Ciacco; M. Cappa; C. Torelli; V. Cauvin; S. Tumini; D. Iafusco; F. Barbetti

doi:10.1007/s00125-006-0329-x

Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]

G. Tonini, C. Bizzarri, R. Bonfanti, M. Vanelli, F. Cerutti, E. Faleschini, F. Meschi, F. Prisco, E. Ciacco, M. Cappa, C. Torelli, V. Cauvin, S. Tumini, D. Iafusco, F. Barbetti

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2210-2213
Number of pages	4
Journal	Diabetologia
Volume	49
Issue number	9
DOIs	https://doi.org/10.1007/s00125-006-0329-x
Publication status	Published - Sept 2006

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.1007/s00125-006-0329-x

Cite this

Tonini, G., Bizzarri, C., Bonfanti, R., Vanelli, M., Cerutti, F., Faleschini, E., Meschi, F., Prisco, F., Ciacco, E., Cappa, M., Torelli, C., Cauvin, V., Tumini, S., Iafusco, D., & Barbetti, F. (2006). Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]. Diabetologia, 49(9), 2210-2213. https://doi.org/10.1007/s00125-006-0329-x

Tonini, G, Bizzarri, C, Bonfanti, R, Vanelli, M, Cerutti, F, Faleschini, E, Meschi, F, Prisco, F, Ciacco, E, Cappa, M, Torelli, C, Cauvin, V, Tumini, S, Iafusco, D & Barbetti, F 2006, 'Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]', Diabetologia, vol. 49, no. 9, pp. 2210-2213. https://doi.org/10.1007/s00125-006-0329-x

@article{3b4ce3b7bf584ee483f51df830dcd686,

title = "Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]",

author = "G. Tonini and C. Bizzarri and R. Bonfanti and M. Vanelli and F. Cerutti and E. Faleschini and F. Meschi and F. Prisco and E. Ciacco and M. Cappa and C. Torelli and V. Cauvin and S. Tumini and D. Iafusco and F. Barbetti",

year = "2006",

month = sep,

doi = "10.1007/s00125-006-0329-x",

language = "English",

volume = "49",

pages = "2210--2213",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Verlag",

number = "9",

}

TY - JOUR

T1 - Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]

AU - Tonini, G.

AU - Bizzarri, C.

AU - Bonfanti, R.

AU - Vanelli, M.

AU - Cerutti, F.

AU - Faleschini, E.

AU - Meschi, F.

AU - Prisco, F.

AU - Ciacco, E.

AU - Cappa, M.

AU - Torelli, C.

AU - Cauvin, V.

AU - Tumini, S.

AU - Iafusco, D.

AU - Barbetti, F.

PY - 2006/9

Y1 - 2006/9

UR - http://www.scopus.com/inward/record.url?scp=33746738864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746738864&partnerID=8YFLogxK

U2 - 10.1007/s00125-006-0329-x

DO - 10.1007/s00125-006-0329-x

M3 - Article

C2 - 16816952

AN - SCOPUS:33746738864

SN - 0012-186X

VL - 49

SP - 2210

EP - 2213

JO - Diabetologia

JF - Diabetologia

IS - 9

ER -

Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene [1]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this